51
|
van Boven N, Akkerhuis KM, Anroedh SS, Rizopoulos D, Pinto Y, Battes LC, Hillege HL, Caliskan KC, Germans T, Manintveld OC, Cornel JH, Constantinescu AA, Boersma E, Umans VA, Kardys I. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study. Int J Cardiol 2017; 235:124-132. [PMID: 28274577 DOI: 10.1016/j.ijcard.2017.02.078] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/05/2016] [Revised: 01/15/2017] [Accepted: 02/20/2017] [Indexed: 12/20/2022]
Abstract
BACKGROUND Several studies have suggested circulating microRNAs (miRs) are associated with heart failure, but these studies were small, and limited to single miR measurements. We examined 7 miRs which were previously linked to heart failure, and tested whether their temporal expression level predicts prognosis in a prospective cohort of chronic heart failure (CHF) patients. METHODS AND RESULTS In 2011-2013, 263 CHF patients were included. At inclusion and subsequently every 3months, we measured 7miRs. The primary endpoint (PE) comprised heart failure hospitalization, cardiovascular mortality, cardiac transplantation and LVAD implantation. Associations between temporal miR patterns and the PE were investigated by joint modelling, which combines mixed models with Cox regression. Mean age was 67±13years, 72% were men and 27% NYHA classes III-IV. We obtained 873 blood samples (median 3 [IQR 2-5] per patient). The PE was reached in 41 patients (16%) during a median follow-up of 0.9 [0.6-1.4] years. The temporal pattern of miR-22-3p was independently associated with the PE (HR [95% CI] per doubling of level: 0.64 [0.47-0.77]). The instantaneous change in level (slope of the temporal miR pattern) of miR-22-3p was also independently associated with the PE (HR [95% CI] per doubling of slope: 0.33 [0.20-0.51]). These associations remained statistically significant after adjustment for temporal patterns of NT-proBNP, Troponin T and CRP. CONCLUSIONS The temporal pattern of circulating miR-22-3p contains important prognostic and independent information in CHF patients. This concept warrants further investigation in larger series with extended follow-up.
Collapse
Affiliation(s)
- Nick van Boven
- Cardiology, Medical Centre Alkmaar, Alkmaar, The Netherlands
| | | | | | | | - Yigal Pinto
- Cardiology, Academic Medical Centre, Amsterdam, The Netherlands
| | - Linda C Battes
- Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands
| | - Hans L Hillege
- Cardiology, University Medical Centre Groningen, Groningen, The Netherlands
| | | | - Tjeerd Germans
- Cardiology, Medical Centre Alkmaar, Alkmaar, The Netherlands
| | | | - Jan-Hein Cornel
- Cardiology, Medical Centre Alkmaar, Alkmaar, The Netherlands
| | | | - Eric Boersma
- Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands
| | - Victor A Umans
- Cardiology, Medical Centre Alkmaar, Alkmaar, The Netherlands
| | - Isabella Kardys
- Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
| |
Collapse
|
52
|
Metra M. December 2016 at a glance: cardiac metabolism, myocarditis, right ventricular function and prognostic markers. Eur J Heart Fail 2016; 18:1403-1404. [PMID: 27910286 DOI: 10.1002/ejhf.710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- Marco Metra
- Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Italy
| |
Collapse
|
53
|
Rubiś P, Totoń-Żurańska J, Wiśniowska-Śmiałek S, Holcman K, Kołton-Wróż M, Wołkow P, Wypasek E, Natorska J, Rudnicka-Sosin L, Pawlak A, Kozanecki A, Podolec P. Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy. Int J Cardiol 2016; 231:201-206. [PMID: 27889210 DOI: 10.1016/j.ijcard.2016.11.279] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2016] [Accepted: 11/14/2016] [Indexed: 11/17/2022]
Affiliation(s)
- Paweł Rubiś
- Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland.
| | - Justyna Totoń-Żurańska
- Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland
| | | | - Katarzyna Holcman
- Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland
| | - Maria Kołton-Wróż
- Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland
| | - Paweł Wołkow
- Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland
| | - Ewa Wypasek
- Department of Molecular Biology, John Paul II Hospital, Krakow, Poland
| | - Joanna Natorska
- Department of Molecular Biology, John Paul II Hospital, Krakow, Poland
| | | | - Agnieszka Pawlak
- Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland; 2nd Central Hospital of the Ministry of Interior, Department of Cardiology, Warsaw, Poland
| | - Artur Kozanecki
- Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland
| | - Piotr Podolec
- Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland; Jagiellonian University, Medical Collage, Krakow, Poland
| |
Collapse
|
54
|
Verdonschot J, Hazebroek M, Merken J, Debing Y, Dennert R, Brunner-La Rocca HP, Heymans S. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail 2016; 18:1430-1441. [PMID: 27748022 DOI: 10.1002/ejhf.665] [Citation(s) in RCA: 90] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2016] [Revised: 08/24/2016] [Accepted: 08/29/2016] [Indexed: 12/24/2022] Open
Abstract
Over the last decade, parvovirus B19 (B19V) has frequently been linked to the pathogenesis of myocarditis (MC) and its progression towards dilated cardiomyopathy (DCM). The exact role of the presence of B19V and its load remains controversial, as this virus is also found in the heart of healthy subjects. Moreover, the prognostic relevance of B19V prevalence in endomyocardial biopsies still remains unclear. As a result, it is unclear whether the presence of B19V should be treated. This review provides an overview of recent literature investigating the presence of B19V and its pathophysiological relevance in MC and DCM, as well as in normal hearts. In brief, no difference in B19V prevalence is observed between MC/DCM and healthy control hearts. Therefore, the question remains open whether and how cardiac B19V may be of pathogenetic importance. Findings suggest that B19V is aetiologically relevant either in the presence of other cardiotropic viruses, or when B19V load is high and/or actively replicating, which both may maintain myocardial (low-grade) inflammation. Therefore, future studies should focus on the prognostic relevance of the viral load, replicative status and virus co-infections. In addition, the immunogenetic background of MC/DCM patients that makes them susceptible to develop heart failure upon presence of B19V should be more thoroughly investigated.
Collapse
Affiliation(s)
- Job Verdonschot
- Department of Cardiology, CARIM, Maastricht University Medical Centre, the Netherlands
| | - Mark Hazebroek
- Department of Cardiology, CARIM, Maastricht University Medical Centre, the Netherlands
| | - Jort Merken
- Department of Cardiology, CARIM, Maastricht University Medical Centre, the Netherlands
| | - Yannick Debing
- Department of Cardiology, CARIM, Maastricht University Medical Centre, the Netherlands
| | - Robert Dennert
- Department of Cardiology, CARIM, Maastricht University Medical Centre, the Netherlands
| | | | - Stephane Heymans
- Department of Cardiology, CARIM, Maastricht University Medical Centre, the Netherlands
| |
Collapse
|